StockData
Pacific Biosciences of California, Inc. logo

Pacific Biosciences of California, Inc. (PACB) stock

PACBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$1.82−0.02 (-1.09%)

Close on Nov 17, 2026Market cap $565.71MP/E –Yield 0.00%

Pacific Biosciences of California pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Pacific Biosciences of California's pe ratio was 195.2× on Apr 30, 2021.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Apr 30, 2021195.2×–

More Pacific Biosciences of California figures

See a number that looks wrong?